Global Equine Pharmaceuticals and Supplements Market Research Report 2022(Status and Outlook)
Global Equine Pharmaceuticals and Supplements Market Research Report 2022(Status and Outlook)
Abstract
Report Overview
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 5%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 3 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 8%. And in terms of application, the largest application is Thoroughbred Horse, etc.
The Global Equine Pharmaceuticals and Supplements Market Size was estimated at USD 1105.21 million in 2021 and is projected to reach USD 1508.58 million by 2028, exhibiting a CAGR of 4.54% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Equine Pharmaceuticals and Supplements market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Equine Pharmaceuticals and Supplements Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Equine Pharmaceuticals and Supplements market in any manner.
Global Equine Pharmaceuticals and Supplements Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
•Boehringer Ingelheim
•Merck Animal Health
•Zoetis
•Bayer Animal Health
•Elanco Animal Health
•Dechra Veterinary Products
•CEVA
•Virbac
•Norbrook Equine
•Kyoritsu Seiyaku
•Vetoquinol
•Protexin Healthcare
•Audevard
•Ouro Fino Saude
Market Segmentation (by Type)
•Pharmaceuticals
•Supplements
Market Segmentation (by Application)
•Thoroughbred Horse
•Other Types of Horses
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Equine Pharmaceuticals and Supplements Market
• Overview of the regional outlook of the Equine Pharmaceuticals and Supplements Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Pharmaceuticals and Supplements Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Content
TABLE OF CONTENTS
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Equine Pharmaceuticals and Supplements
1.2 Key Market Segments
1.2.1 Equine Pharmaceuticals and Supplements Segment by Type
1.2.2 Equine Pharmaceuticals and Supplements Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Equine Pharmaceuticals and Supplements Market Overview
2.1 Global Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Equine Pharmaceuticals and Supplements Market Competitive Landscape
3.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2017-2022)
3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2017-2022)
3.3 Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Equine Pharmaceuticals and Supplements Sales Sites, Area Served, Product Type
3.6 Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
3.6.1 Equine Pharmaceuticals and Supplements Market Concentration Rate
3.6.2 Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Equine Pharmaceuticals and Supplements Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Equine Pharmaceuticals and Supplements Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2017-2022)
6.3 Global Equine Pharmaceuticals and Supplements Market Size Market Share by Type (2017-2022)
6.4 Global Equine Pharmaceuticals and Supplements Price by Type (2017-2022)
7 Equine Pharmaceuticals and Supplements Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Pharmaceuticals and Supplements Market Sales by Application (2017-2022)
7.3 Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2017-2022)
7.4 Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2017-2022)
8 Equine Pharmaceuticals and Supplements Market Segmentation by Region
8.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region
8.2 North America
8.2.1 North America Equine Pharmaceuticals and Supplements Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Equine Pharmaceuticals and Supplements Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Equine Pharmaceuticals and Supplements Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Basic Information
9.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
9.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Market Performance
9.1.4 Boehringer Ingelheim Business Overview
9.1.5 Boehringer Ingelheim Equine Pharmaceuticals and Supplements SWOT Analysis
9.1.6 Boehringer Ingelheim Recent Developments
9.2 Merck Animal Health
9.2.1 Merck Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.2.4 Merck Animal Health Business Overview
9.2.5 Merck Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
9.2.6 Merck Animal Health Recent Developments
9.3 Zoetis
9.3.1 Zoetis Equine Pharmaceuticals and Supplements Basic Information
9.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Overview
9.3.3 Zoetis Equine Pharmaceuticals and Supplements Product Market Performance
9.3.4 Zoetis Business Overview
9.3.5 Zoetis Equine Pharmaceuticals and Supplements SWOT Analysis
9.3.6 Zoetis Recent Developments
9.4 Bayer Animal Health
9.4.1 Bayer Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.4.4 Bayer Animal Health Business Overview
9.4.5 Bayer Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
9.4.6 Bayer Animal Health Recent Developments
9.5 Elanco Animal Health
9.5.1 Elanco Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.5.4 Elanco Animal Health Business Overview
9.5.5 Elanco Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
9.5.6 Elanco Animal Health Recent Developments
9.6 Dechra Veterinary Products
9.6.1 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Basic Information
9.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
9.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Market Performance
9.6.4 Dechra Veterinary Products Business Overview
9.6.5 Dechra Veterinary Products Recent Developments
9.7 CEVA
9.7.1 CEVA Equine Pharmaceuticals and Supplements Basic Information
9.7.2 CEVA Equine Pharmaceuticals and Supplements Product Overview
9.7.3 CEVA Equine Pharmaceuticals and Supplements Product Market Performance
9.7.4 CEVA Business Overview
9.7.5 CEVA Recent Developments
9.8 Virbac
9.8.1 Virbac Equine Pharmaceuticals and Supplements Basic Information
9.8.2 Virbac Equine Pharmaceuticals and Supplements Product Overview
9.8.3 Virbac Equine Pharmaceuticals and Supplements Product Market Performance
9.8.4 Virbac Business Overview
9.8.5 Virbac Recent Developments
9.9 Norbrook Equine
9.9.1 Norbrook Equine Equine Pharmaceuticals and Supplements Basic Information
9.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
9.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product Market Performance
9.9.4 Norbrook Equine Business Overview
9.9.5 Norbrook Equine Recent Developments
9.10 Kyoritsu Seiyaku
9.10.1 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Basic Information
9.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
9.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Market Performance
9.10.4 Kyoritsu Seiyaku Business Overview
9.10.5 Kyoritsu Seiyaku Recent Developments
9.11 Vetoquinol
9.11.1 Vetoquinol Equine Pharmaceuticals and Supplements Basic Information
9.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
9.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product Market Performance
9.11.4 Vetoquinol Business Overview
9.11.5 Vetoquinol Recent Developments
9.12 Protexin Healthcare
9.12.1 Protexin Healthcare Equine Pharmaceuticals and Supplements Basic Information
9.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
9.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Market Performance
9.12.4 Protexin Healthcare Business Overview
9.12.5 Protexin Healthcare Recent Developments
9.13 Audevard
9.13.1 Audevard Equine Pharmaceuticals and Supplements Basic Information
9.13.2 Audevard Equine Pharmaceuticals and Supplements Product Overview
9.13.3 Audevard Equine Pharmaceuticals and Supplements Product Market Performance
9.13.4 Audevard Business Overview
9.13.5 Audevard Recent Developments
9.14 Ouro Fino Saude
9.14.1 Ouro Fino Saude Equine Pharmaceuticals and Supplements Basic Information
9.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
9.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Market Performance
9.14.4 Ouro Fino Saude Business Overview
9.14.5 Ouro Fino Saude Recent Developments
10 Equine Pharmaceuticals and Supplements Market Forecast by Region
10.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast
10.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country
10.2.3 Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region
10.2.4 South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Equine Pharmaceuticals and Supplements Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Equine Pharmaceuticals and Supplements by Type (2022-2028)
11.1.2 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Equine Pharmaceuticals and Supplements by Type (2022-2028)
11.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Application (2022-2028)
11.2.1 Global Equine Pharmaceuticals and Supplements Sales (K Units) Forecast by Application
11.2.2 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 5%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 3 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 8%. And in terms of application, the largest application is Thoroughbred Horse, etc.
The Global Equine Pharmaceuticals and Supplements Market Size was estimated at USD 1105.21 million in 2021 and is projected to reach USD 1508.58 million by 2028, exhibiting a CAGR of 4.54% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Equine Pharmaceuticals and Supplements market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Equine Pharmaceuticals and Supplements Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Equine Pharmaceuticals and Supplements market in any manner.
Global Equine Pharmaceuticals and Supplements Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
•Boehringer Ingelheim
•Merck Animal Health
•Zoetis
•Bayer Animal Health
•Elanco Animal Health
•Dechra Veterinary Products
•CEVA
•Virbac
•Norbrook Equine
•Kyoritsu Seiyaku
•Vetoquinol
•Protexin Healthcare
•Audevard
•Ouro Fino Saude
Market Segmentation (by Type)
•Pharmaceuticals
•Supplements
Market Segmentation (by Application)
•Thoroughbred Horse
•Other Types of Horses
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Equine Pharmaceuticals and Supplements Market
• Overview of the regional outlook of the Equine Pharmaceuticals and Supplements Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Pharmaceuticals and Supplements Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Equine Pharmaceuticals and Supplements
1.2 Key Market Segments
1.2.1 Equine Pharmaceuticals and Supplements Segment by Type
1.2.2 Equine Pharmaceuticals and Supplements Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Equine Pharmaceuticals and Supplements Market Overview
2.1 Global Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Equine Pharmaceuticals and Supplements Market Competitive Landscape
3.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2017-2022)
3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2017-2022)
3.3 Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Equine Pharmaceuticals and Supplements Sales Sites, Area Served, Product Type
3.6 Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
3.6.1 Equine Pharmaceuticals and Supplements Market Concentration Rate
3.6.2 Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Equine Pharmaceuticals and Supplements Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Equine Pharmaceuticals and Supplements Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2017-2022)
6.3 Global Equine Pharmaceuticals and Supplements Market Size Market Share by Type (2017-2022)
6.4 Global Equine Pharmaceuticals and Supplements Price by Type (2017-2022)
7 Equine Pharmaceuticals and Supplements Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Pharmaceuticals and Supplements Market Sales by Application (2017-2022)
7.3 Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2017-2022)
7.4 Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2017-2022)
8 Equine Pharmaceuticals and Supplements Market Segmentation by Region
8.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region
8.2 North America
8.2.1 North America Equine Pharmaceuticals and Supplements Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Equine Pharmaceuticals and Supplements Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Equine Pharmaceuticals and Supplements Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Basic Information
9.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
9.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Market Performance
9.1.4 Boehringer Ingelheim Business Overview
9.1.5 Boehringer Ingelheim Equine Pharmaceuticals and Supplements SWOT Analysis
9.1.6 Boehringer Ingelheim Recent Developments
9.2 Merck Animal Health
9.2.1 Merck Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.2.4 Merck Animal Health Business Overview
9.2.5 Merck Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
9.2.6 Merck Animal Health Recent Developments
9.3 Zoetis
9.3.1 Zoetis Equine Pharmaceuticals and Supplements Basic Information
9.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Overview
9.3.3 Zoetis Equine Pharmaceuticals and Supplements Product Market Performance
9.3.4 Zoetis Business Overview
9.3.5 Zoetis Equine Pharmaceuticals and Supplements SWOT Analysis
9.3.6 Zoetis Recent Developments
9.4 Bayer Animal Health
9.4.1 Bayer Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.4.4 Bayer Animal Health Business Overview
9.4.5 Bayer Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
9.4.6 Bayer Animal Health Recent Developments
9.5 Elanco Animal Health
9.5.1 Elanco Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.5.4 Elanco Animal Health Business Overview
9.5.5 Elanco Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
9.5.6 Elanco Animal Health Recent Developments
9.6 Dechra Veterinary Products
9.6.1 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Basic Information
9.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
9.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Market Performance
9.6.4 Dechra Veterinary Products Business Overview
9.6.5 Dechra Veterinary Products Recent Developments
9.7 CEVA
9.7.1 CEVA Equine Pharmaceuticals and Supplements Basic Information
9.7.2 CEVA Equine Pharmaceuticals and Supplements Product Overview
9.7.3 CEVA Equine Pharmaceuticals and Supplements Product Market Performance
9.7.4 CEVA Business Overview
9.7.5 CEVA Recent Developments
9.8 Virbac
9.8.1 Virbac Equine Pharmaceuticals and Supplements Basic Information
9.8.2 Virbac Equine Pharmaceuticals and Supplements Product Overview
9.8.3 Virbac Equine Pharmaceuticals and Supplements Product Market Performance
9.8.4 Virbac Business Overview
9.8.5 Virbac Recent Developments
9.9 Norbrook Equine
9.9.1 Norbrook Equine Equine Pharmaceuticals and Supplements Basic Information
9.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
9.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product Market Performance
9.9.4 Norbrook Equine Business Overview
9.9.5 Norbrook Equine Recent Developments
9.10 Kyoritsu Seiyaku
9.10.1 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Basic Information
9.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
9.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Market Performance
9.10.4 Kyoritsu Seiyaku Business Overview
9.10.5 Kyoritsu Seiyaku Recent Developments
9.11 Vetoquinol
9.11.1 Vetoquinol Equine Pharmaceuticals and Supplements Basic Information
9.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
9.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product Market Performance
9.11.4 Vetoquinol Business Overview
9.11.5 Vetoquinol Recent Developments
9.12 Protexin Healthcare
9.12.1 Protexin Healthcare Equine Pharmaceuticals and Supplements Basic Information
9.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
9.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Market Performance
9.12.4 Protexin Healthcare Business Overview
9.12.5 Protexin Healthcare Recent Developments
9.13 Audevard
9.13.1 Audevard Equine Pharmaceuticals and Supplements Basic Information
9.13.2 Audevard Equine Pharmaceuticals and Supplements Product Overview
9.13.3 Audevard Equine Pharmaceuticals and Supplements Product Market Performance
9.13.4 Audevard Business Overview
9.13.5 Audevard Recent Developments
9.14 Ouro Fino Saude
9.14.1 Ouro Fino Saude Equine Pharmaceuticals and Supplements Basic Information
9.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
9.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Market Performance
9.14.4 Ouro Fino Saude Business Overview
9.14.5 Ouro Fino Saude Recent Developments
10 Equine Pharmaceuticals and Supplements Market Forecast by Region
10.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast
10.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country
10.2.3 Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region
10.2.4 South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Equine Pharmaceuticals and Supplements Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Equine Pharmaceuticals and Supplements by Type (2022-2028)
11.1.2 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Equine Pharmaceuticals and Supplements by Type (2022-2028)
11.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Application (2022-2028)
11.2.1 Global Equine Pharmaceuticals and Supplements Sales (K Units) Forecast by Application
11.2.2 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
Related Report
